BioCurex Inc. Signs Consent to Transfer Abbott Laboratories’s RECAF Licensing Agreement to General Electric Company

RICHMOND, British Columbia, July 2, 2007 (PRIME NEWSWIRE) -- BioCurex, Inc. (OTCBB:BOCX) announced today that, upon request from Abbott Labs, the Company has signed a document transferring Abbott’s RECAF licensing agreement to General Electric (GE).

MORE ON THIS TOPIC